Hypoxic regulation of vascular endothelial growth factor in retinal cells - PubMed (original) (raw)

Hypoxic regulation of vascular endothelial growth factor in retinal cells

L P Aiello et al. Arch Ophthalmol. 1995 Dec.

Abstract

Background: Vascular endothelial growth factor (VEGF) is an angiogenic protein and vasopermeability factor whose intraocular concentrations are closely correlated with active neovascularization in patients with diabetes mellitus, central retinal vein occlusion, retinopathy of prematurity, and rubeosis iridis.

Objective: To determine whether hypoxia could induce expression of VEGF in retinal cells, which then promotes retinal endothelial cell proliferation.

Methods: Retinal pigment epithelial cells, pericytes, and microvascular endothelial cells were exposed to hypoxic conditions in vitro, and RNA expression of VEGF was evaluated by Northern blot analysis. The VEGF-specific proliferative potential of the medium was measured by means of retinal endothelial cell growth assays and VEGF-neutralizing VEGF receptor IgG chimeric protein.

Results: The VEGF RNA levels increased within 4 hours and reached elevations of threefold to 30-fold after 18 hours of hypoxia (0% to 5% oxygen, 5% carbon dioxide, 90% to 95% nitrogen) in all cell types (.01 < P < .03). Stimulation was dependent on oxygen concentration. The VEGF RNA levels were normalized by reinstitution of normoxia for 24 hours (P < .004). Medium conditioned by hypoxic retinal pericytes and retinal pigment epithelial cells stimulated retinal endothelial cell growth by 20% (P = .04), and this stimulation was entirely inhibited by VEGF-neutralizing receptor chimeric protein (P = .02).

Conclusion: Hypoxia increases VEGF expression in retinal cells, which promotes retinal endothelial cell proliferation, suggesting that VEGF plays a major role in mediating intraocular neovascularization resulting from ischemic retinal diseases.

PubMed Disclaimer

Cited by

Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK, Zhao Y, Shen W, Coleman P, Yam M, Chan-Ling T, Li J, Moller T, Gillies M, Vadas MA, Gamble JR. Ting KK, et al. Diabetologia. 2019 Feb;62(2):322-334. doi: 10.1007/s00125-018-4770-4. Epub 2018 Nov 15. Diabetologia. 2019. PMID: 30443753
Regulation of retinal capillary cells by basic fibroblast growth factor, vascular endothelial growth factor, and hypoxia.
Yan Q, Li Y, Hendrickson A, Sage EH. Yan Q, et al. In Vitro Cell Dev Biol Anim. 2001 Jan;37(1):45-9. doi: 10.1290/1071-2690(2001)037<0045:RORCCB>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2001. PMID: 11249204
Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.
Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N. Lashkari K, et al. Am J Pathol. 2000 Apr;156(4):1337-44. doi: 10.1016/S0002-9440(10)65004-3. Am J Pathol. 2000. PMID: 10751359 Free PMC article.
Müller cells as players in retinal degeneration and edema.
Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A. Reichenbach A, et al. Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):627-36. doi: 10.1007/s00417-006-0516-y. Epub 2007 Jan 12. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17219109 Review.
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy.
Scuteri D, Vero A, Zito M, Naturale MD, Bagetta G, Nucci C, Tonin P, Corasaniti MT. Scuteri D, et al. Neural Regen Res. 2019 Aug;14(8):1445-1448. doi: 10.4103/1673-5374.253528. Neural Regen Res. 2019. PMID: 30964071 Free PMC article.

Hypoxic regulation of vascular endothelial growth factor in retinal cells - PubMed (original) (raw)